26.12.2014 Views

Clinical Biochemistry of Domestic Animals (Sixth Edition) - UMK ...

Clinical Biochemistry of Domestic Animals (Sixth Edition) - UMK ...

Clinical Biochemistry of Domestic Animals (Sixth Edition) - UMK ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

IV. Laboratory Assessment <strong>of</strong> Hepatic Function<br />

395<br />

TABLE 13-6 Serum y-Glutamyltransferase (GGT) Activity in <strong>Animals</strong> with Hepatobiliary<br />

Diseases<br />

Species Condition References<br />

Dog Bile duct obstruction; chronic hepatitis Braun et al . (1983)<br />

Lipidosis; necrosis; cirrhosis; neoplasia Hauge and Abdelkader (1984)<br />

Corticoid therapy De Novo and Prasse (1983)<br />

Cat<br />

Bile duct obstruction; cholangiohepatitis;<br />

cirrhosis; lymphosarcoma; necrosis<br />

Center et al . (1986)<br />

Horse Toxic hepatic failure Divers et al . (1983)<br />

Subclinical hepatopathy Yamaoka et al . (1978)<br />

Hyperlipemia Wensing et al . (1973)<br />

Cow Ragwort poisoning; fascioliasis lipidosis Blackshaw (1978)<br />

Fascioliasis metacercariae migrations and<br />

Simesen et al . (1973)<br />

chronicity<br />

Metacercariae migrations Bulgin and Anderson (1984)<br />

Senecio poisoning Johnson and Molyneux (1984)<br />

Sheep<br />

Bile duct obstruction; sporidesmin; toxicity;<br />

Ford and Evans (1985)<br />

fascioliasis<br />

Lupinosis Malherbe et al . (1977)<br />

Cobalt deficiency (white liver disease) Sutherland et al . (1979)<br />

Ketosis Meissonier and Rousseau (1976)<br />

Pig Cysticercus tenuicollis infection Enigk et al . (1976)<br />

Arsanilic acid toxicity Ferslew and Edds (1979)<br />

mobilization ( “ solubilization ” ) <strong>of</strong> GGT from its membrane<br />

anchor related to elevated levels <strong>of</strong> bile salts ( Center,<br />

2007 ).<br />

Highest tissue levels <strong>of</strong> GGT in the dog and cat are<br />

present in the kidney and pancreas with lesser amounts in<br />

the liver, gallbladder, intestines, spleen, heart, lungs, skeletal<br />

muscle, and erythrocytes (Badylak et al., 1982; Braun<br />

et al., 1983 ; Guelfi et al., 1982 ). The activity <strong>of</strong> GGT in<br />

serum is derived primarily from the liver although, as<br />

stated previously, there is considerable species variation in<br />

GGT activity within this organ. Hepatic localization has<br />

been demonstrated in the canaliculus, in bile ducts, and in<br />

Zone 1 hepatocytes ( Aronsen et al., 1968 ; Braun et al.,<br />

1983 ; Center, 2005) .<br />

The diagnostic value <strong>of</strong> GGT has been assessed in clinical<br />

patients with and without liver disease ( Center et al.,<br />

1986, 1992 ; Guelfi et al., 1982 ). Experimental studies in<br />

dogs and cats undergoing acute, severe diffuse necrosis<br />

have shown either no change in serum GGT or only mild<br />

increases in activity (1- to 3-fold normal) that resolve over<br />

the ensuing 10 days. In the dog, extrahepatic bile duct<br />

obstruction causes serum GGT activity to increase 1- to<br />

4-fold within 4 days, and 10- to 50-fold within 1 to 2<br />

weeks. Thereafter, values may plateau or continue to<br />

increase as high as 100-fold that <strong>of</strong> normal ( Guelfi et al.,<br />

1982 ; Kokot et al., 1965 ; Noonan and Meyer, 1979 ). In<br />

the cat with extrahepatic bile duct obstruction, serum GGT<br />

activity may increase up to 2-fold within 3 days, 2- to 6-<br />

fold within 5 days, and 4- to 16-fold that <strong>of</strong> normal within<br />

2 weeks ( Meyer, 1983 ; Spano et al., 1983 ).<br />

Glucocorticoids and certain other microsomal enzyme<br />

inducers may stimulate production <strong>of</strong> GGT in the dog<br />

similar to the influence <strong>of</strong> such drugs or other xenobiotics<br />

on AP. Administration <strong>of</strong> dexamethasone (3mg/kg SID)<br />

or prednisone (4.4 mg/kg SID IM) increased GGT activity<br />

within 1 week 4- to 7-fold and up to 10-fold within 2 weeks<br />

( Badylak and Van Vleet, 1981, 1982 ; Stein et al., 1989 ). It<br />

is assumed that the increased production <strong>of</strong> GGT following<br />

glucocorticoid administration originates in the liver. In<br />

comparison to glucocorticoid induction, dogs treated with<br />

the anticonvulsants phenytoin or primidone develop only<br />

modest increases in serum GGT activity up to 2- or 3-fold<br />

that <strong>of</strong> normal unless they develop serious anticonvulsant<br />

hepatotoxicosis ( Bunch et al., 1985, 1987 ) .<br />

Some cats with advanced necroinflammatory liver disease,<br />

major bile duct obstruction, or intrahepatic cholestasis<br />

develop relatively greater increases in GGT than in AP<br />

activity ( Center et al., 1986 ). In other species, cholestasis is<br />

known to enhance enzyme synthesis as well as membrane<br />

release <strong>of</strong> GGT. It remains undetermined whether glucocorticoids<br />

or other enzyme inducers increase the expression<br />

<strong>of</strong> GGT in cats. It is noteworthy that the normal range<br />

for feline serum GGT activity is narrower and lower than<br />

that <strong>of</strong> the dog, so the interpretation <strong>of</strong> feline GGT activity

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!